• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

LSP BioVentures

edit

LSP BioVentures is a venture capital fund focused on opportunities in the life science arena. Based in Cambridge (MA) in the USA; the fund’s management combines the strength of its parent company, Life Sciences Partners Venture Capital firm in Europe and a dedicated team of experts in the USA.

Recent Milestones

edit

• 
  LSP BioVentures invested in arGEN-X. (12/1/11)
  Posted 12/1/11 at 5:11am via finsmes.com
• 
  LSP BioVentures invested in Activaero. (2/16/11)
  Posted 2/16/11 at 6:15pm via cnbc.com
• 
  LSP BioVentures invested in Syntaxin. (11/11/10)
  Posted 11/11/10 at 6:27pm via fiercebiotech.com
• 
  LSP BioVentures invested in Pasteuria Bioscience. (5/1/07)
  Posted 6/8/09 at 2:17am

Investments

Videos

Sources

1. arGEN-X Closes €27.5M Series B Funding Round (finsmes.com) [edit]
2. Activaero Raises EUR 5.0 Million ($ 6.8 Million) In a Second Closing Series a Round Led By LSP (cnbc.com) [edit]
3. VCs inject $29M into Syntaxin, $11.5M into Ceregene (fiercebiotech.com) [edit]
4. EDGAR [edit]